从统计推断到机器学习:当代心血管药物治疗中的范式转变
Marin Pavlov1, Domjan Barić2, Andrej Novak1,2
1Department of Cardiology, Dubrava University Hospital, Zagreb, Croatia.
British journal of clinical pharmacology
|October 16, 2023
概括
机器学习,特别是XGBoost,确定了心力衰竭的改善结果的关键预测因子,降低了喷射率 (HFrEF) 的患者,优于传统的统计方法. 这种人工智能方法为复杂的HFrEF数据集提供了更深入的见解.
科学领域:
- 心脏病学 心脏病学
- 医疗信息学 医疗信息学
- 人工智能的人工智能
背景情况:
- 减少喷射分数 (HFrEF) 的心力衰竭带来了复杂的临床挑战.
- 人工智能 (AI) 为分析复杂的临床数据提供了新的方法.
- 机器学习 (ML) 可以揭示对HFrEF患者数据集的更深入的见解.
研究的目的:
- 在HFrEF患者数据中探索ML算法的预测潜力.
- 确定影响HFrEF长期结果的关键因素.
- 将基于ML的预测与传统的统计分析进行比较.
主要方法:
- 对386名HFrEF患者队列的分析,至少进行6个月的随访.
- 应用极端梯度提升 (XGBoost) 算法.
- 使用Shapley添加式解释 (SHAP) 进行模型解释.
主要成果:
- 传统方法显示了关联,但缺乏关键药理因素的独立预测能力.
- XGBoost确定了"新开始的sacubitril/valsartan治疗"和"β-阻断剂 (BB) 剂量升级"作为强有力的预测因素.
- XGBoost有效地处理了非线性分布,多线性和混因素.
结论:
- ML,特别是XGBoost与SHAP,为HFrEF结果提供了显著的预测能力.
- 这种方法提供了超越传统统计模型的宝贵见解.
- 考虑局限性,包括临床上无关紧要的预测因素的可能性,至关重要.
相关概念视频
Model Approaches for Pharmacokinetic Data: Physiological Models
52
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
52
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
70
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
70
Analysis of Population Pharmacokinetic Data
267
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
267
Cardiovascular Drugs: Classification based on Therapeutic Indications
2.9K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.9K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
174
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
174
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
141
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
141


